Synthetic antibodies have become the cornerstone of cancer therapies. This approach was also favored in the initial fight against COVID-19. However, their laboratory production is time-consuming ...

Applications include generating antibodies against specific ... are the protein equivalent of synthetic oligonucleotides, and to some extent the two technologies have had parallel histories. But where ...

In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.

This innovative approach offers a faster, more affordable way to create synthetic molecules that work like antibodies, potentially revolutionizing treatments for diseases such as cancer and COVID-19.

High throughput (HTP) gene to antibody production provides the most cost effective option for small-scale recombinant antibodies. This popular service combines GenScript's expertise in high-throughput ...

As well as helping companies overcome the bottlenecks that stem from the DNA synthesis process in antibody discovery, Twist antibody optimization (TAO) services facilitate the identification of ...

In little more than five years, German biotechnology company YUMAB (a phonetic play on HUMAB (human monoclonal antibody ... or humanized or synthetic mAbs—YUMAB’s fully human mAbs maximize ...

Prof. Göpfrich's work starts with the question of how synthetic cells can be created that bypass protein synthesis, which is essential in living cells. She uses the technique of RNA origami ...

Biopharmaceuticals represent another significant market segment, holding a dominant share of 44.2%. The increasing emphasis on biologics, gene therapies, and personalized medicine is fueling the ...

Due to the scale of synthesis enabled by ... including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development.